Trial intelligence / Profile preview

Levodopa/carbidopa crossover validation study of finger tapping tasks in Parkinson's disease

NL-OMON49757Completed

Sponsor
Centre for Human Drug Research
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of levodopa + carbidopa in Parkinson's disease (PD) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Alternate finger tapping task endpoints, Repetitive finger tapping endpoints and 1 more. Started Jul 2020; status: completed.

02

Drugs

levodopa + carbidopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NL-OMON49757.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49757.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call